Prognostic Value of Some Biochemical Markers in Breast Cancer
Not yet recruiting
- Conditions
- Breast Cancer Female
- Interventions
- Diagnostic Test: serum sample for ELIZA
- Registration Number
- NCT05699577
- Lead Sponsor
- Sohag University
- Brief Summary
breast cancer is the most common type of cancer in women and first cause of cancer death among them. in Egypt it constitutes 33% of female cancer cases and more than22000 new cases diagnosed each year. there are many prognostic factors for breast cancer as Tumer size, axillary lymph node status, hormonal receptor status, and tumer markers as Ca15-3 and interferon gamma.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- Female
- Target Recruitment
- 90
Inclusion Criteria
- female patients aged more than or equal 18 year diagnosed with breast cancer
- metastatic and non-metastatic cancer premenopausal and postmenopausal female positive and negative hormonal receptors and HER2 receptor taking any systemic treatment taking radiotherapy or not
Read More
Exclusion Criteria
- female patients less than 18 years patients having comorbid disease. patients with double malignancy
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description metastatic breast cancer serum sample for ELIZA - non metastatic breast cancer serum sample for ELIZA -
- Primary Outcome Measures
Name Time Method serum level of Ca15-3 6 months Tumer marker
serum level of interferon gamma 6 months Tumer marker
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Sohag University Hospital
🇪🇬Sohag, Egypt